Notably, RAC1 expression progressively increases with advancing clinical stage in ACC, BRCA, KIRC, LIHC, and PAAD, suggesting that RAC1 is associated with tumor progression in these cancers. The gene discussed is RAC1; the disease is pancreatic adenocarcinoma.